Exploring how MLH1 and MSH2 DNA repair proteins change in ovarian cancer after platinum chemotherapy and their impact on treatment outcomes.
How scientists are using patient-derived xenograft (PDX) models as avatars of patient tumors to overcome treatment resistance in ovarian cancer.
Exploring the complex role of the tumor microenvironment in ovarian cancer progression and treatment resistance. Is it an overlooked factor or overestimated?